Hepatic sarcoidosis complicating treatment-naive viral hepatitis

doi:10.4254/wjh.v4.i12.402

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 12

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2959)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series.

Item

Count

PDF

244

HTML

2517

Figures (1-4)

198

Sum=2959

Dec 27, 2012 (publication date) through Jul 27, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Hepatol. Dec 27, 2012; 4(12): 402-405
Published online Dec 27, 2012. doi: 10.4254/wjh.v4.i12.402

Full Size Figure Download Figure

Figure 2 The changes in alanine transaminase, alkaline phosphatase and angiotensin converting enzyme levels in patient 1. The dotted arrow and the solid arrow mark the commencement of antiviral treatment and steroid treatment respectively. ALT: Alanine transaminase; ALP: Alkaline phosphatase; ACE: Angiotensin converting enzyme.

Citation: Aravinthan A, Gelson W, Limbu A, Brais R, Richardson P. Hepatic sarcoidosis complicating treatment-naive viral hepatitis. World J Hepatol 2012; 4(12): 402-405
URL: https://www.wjgnet.com/1948-5182/full/v4/i12/402.htm
DOI: https://dx.doi.org/10.4254/wjh.v4.i12.402